Navigating a path to patients

Access Guiding our clients through global payer pathways to ensure launch readiness and deliver on their ambition – providing life-changing treatments to those who need them.

Connect with our Experts

How we can support

Market access in rare diseases and oncology is complex and constantly changing. Each launch is unique, while organisations and reimbursement pathways evolve, meaning our clients must be ready to adapt.

Effectively achieving access demands effective planning, cross-functional alignment and bold, strategic thinking.

At Prescient, we guide our clients through complex global payer pathways to ensure launch readiness and deliver on their ambition – providing life-changing treatments to those who need them.


Our Access services


The numbers

Extensive experience

0

+ Access projects delivered

Diverse geographic knowledge

0

+ Markets navigated

News and Insights

Explore our latest insights, whitepapers, and event highlights to learn more about the latest developments and perspectives shaping the evolving healthcare landscape.

Discover all
Whitepaper

ONWARD panel report: Driving equitable access and system readiness in cancer care 

Find out more
Blog

Cracking the Global Market Access Challenge with the Triple Win

Find out more
Blog

Pharma Market Access Strategies for 2025 and Beyond

Find out more
Blog

Market Access Challenges for Orphan Medicines in the UK

Find out more
Blog

2025 themes for pricing and access success for rare disease and oncology medicines

Find out more

Want to understand how we can optimize your access planning and execution?

If you’re interested in learning more about our services or would like to speak with the team, please get in touch.

Connect with our experts